The Scientist

» drug development and immunology

Most Recent

image: Tetracycline Inventor Dies

Tetracycline Inventor Dies

By | March 15, 2017

Lloyd Conover, a longtime chemist at Pfizer, pioneered the concept of chemically altering natural antibiotics to create new drugs.

0 Comments

image: Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy

Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy

By | February 1, 2017

What can be done to lower development costs and drug prices?

4 Comments

image: Infographic: The Cost of Drug Development

Infographic: The Cost of Drug Development

By | February 1, 2017

Expensive clinical trials and few drug approvals can drive up drug prices for consumers.

0 Comments

image: Pitcher Plant Enzymes Digest Gluten in Mouse Model

Pitcher Plant Enzymes Digest Gluten in Mouse Model

By | February 1, 2017

A newly discovered protease could break down grain proteins that trigger celiac disease.

0 Comments

image: Unique Antibodies Open Path Toward New HIV Vaccines

Unique Antibodies Open Path Toward New HIV Vaccines

By | January 27, 2017

A family of broadly neutralizing antibodies from a chronically infected donor provides a schematic for designing vaccines and treatments that target multiple strains of the virus.

0 Comments

image: Califf Vacates FDA’s Top Post

Califf Vacates FDA’s Top Post

By | January 20, 2017

Robert Califf steps down as FDA Commissioner as Donald Trump takes office.

0 Comments

image: Drug Approval Timeline Same as 20 Years Ago

Drug Approval Timeline Same as 20 Years Ago

By | January 9, 2017

A report finds that new medications still take about 12 years to go from patent to patient.

0 Comments

image: Pharma Redo

Pharma Redo

By | January 1, 2017

Steve Braun of Cures Within Reach, a nonprofit focused on breathing new life into old medicines, describes the potential benefits of drug repurposing.

1 Comment

image: Repurposing Existing Drugs for New Indications

Repurposing Existing Drugs for New Indications

By | January 1, 2017

An entire industry has sprung up around resurrecting failed drugs and recycling existing compounds for novel indications.

1 Comment

image: Infographic: Repurposing Strategies

Infographic: Repurposing Strategies

By | January 1, 2017

Novel uses for existing and failed drugs may save companies time and money in bringing new therapeutics to market.

0 Comments

Popular Now

  1. Trump’s Proposed Budget Would Cut Science Funding
  2. Unstructured Proteins Help Tardigrades Survive Desiccation
  3. Science Advocates Decry Trump’s Proposed Budget
  4. Women Lose Vision After Stem Cell Treatment
Business Birmingham